Inhipraz-D 40 Capsule PR is a combination medication containing Domperidone 30mg and Pantoprazole 40mg, formulated for the management of gastrointestinal disorders. Domperidone, a peripheral dopamine D2 receptor antagonist, enhances gastrointestinal motility and accelerates gastric emptying, thereby alleviating symptoms such as nausea, vomiting, bloating, and gastric discomfort. Pantoprazole, a proton pump inhibitor, suppresses gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase enzyme system in the gastric parietal cells, providing effective relief from acid-related conditions including gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. The combination of these agents offers a dual therapeutic effect by addressing both delayed gastric emptying and excessive acid secretion, improving overall gastrointestinal function. Inhipraz-D 40 Capsule PR is typically prescribed for patients experiencing dyspepsia, GERD with associated motility disorders, and other acid-peptic diseases where enhanced gastric motility and acid suppression are indicated. It is important to use this medication under medical supervision, considering potential contraindications such as hypersensitivity to its components, and to monitor for adverse effects including headache, dry mouth, or gastrointestinal disturbances. Dosage and duration should be individualized based on clinical response and patient tolerance.